Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125765351 | 12576535 | 1 | I | 20160714 | 20160720 | 20160720 | EXP | US-MYLANLABS-2016M1029530 | MYLAN | 0.00 | Y | 0.00000 | 20160720 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125765351 | 12576535 | 1 | PS | Verapamil Hydrochloride Extended-release Tablets, USP | VERAPAMIL HYDROCHLORIDE | 1 | Oral | 240 MG, AM | UNKNOWN | 74587 | 240 | MG | MODIFIED-RELEASE TABLET | QD | |||||
| 125765351 | 12576535 | 2 | SS | Verapamil Hydrochloride Extended-release Tablets, USP | VERAPAMIL HYDROCHLORIDE | 1 | 120MG | UNKNOWN | 74587 | MODIFIED-RELEASE TABLET | |||||||||
| 125765351 | 12576535 | 3 | SS | Verapamil Hydrochloride Extended-release Tablets, USP | VERAPAMIL HYDROCHLORIDE | 1 | Oral | 120 MG, PM | 74587 | 120 | MG | MODIFIED-RELEASE TABLET | QD | ||||||
| 125765351 | 12576535 | 4 | SS | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | Oral | 50 MG, BID | UNKNOWN | 0 | 50 | MG | TABLET | BID | |||||
| 125765351 | 12576535 | 5 | C | NITROGLYCERIN DAK | 2 | Transdermal | UNK | UNKNOWN | 0 | TRANSDERMAL PATCH | |||||||||
| 125765351 | 12576535 | 6 | C | LOSARTAN POTASSIUM ACCORD | 2 | Oral | UNK | UNKNOWN | 0 | ||||||||||
| 125765351 | 12576535 | 7 | C | RAMIPRIL A | RAMIPRIL | 1 | Oral | UNK | UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125765351 | 12576535 | 1 | Hypertension |
| 125765351 | 12576535 | 3 | Hypertension |
| 125765351 | 12576535 | 4 | Hypertension |
| 125765351 | 12576535 | 5 | Hypertension |
| 125765351 | 12576535 | 6 | Hypertension |
| 125765351 | 12576535 | 7 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125765351 | 12576535 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125765351 | 12576535 | Bradycardia | |
| 125765351 | 12576535 | Hypertension | |
| 125765351 | 12576535 | Sleep apnoea syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125765351 | 12576535 | 1 | 2015 | 0 | ||
| 125765351 | 12576535 | 3 | 2015 | 0 |